In vitro prevention of cyclosporin-induced cell contraction by mycophenolic acid.

[1]  W. Bennett,et al.  Mycophenolate Mofetil Ameliorates Arteriolopathy and Decreases Transforming Growth Factor‐β1 in Chronic Cyclosporine Nephrotoxicity , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  J. Bonnet,et al.  Cytoskeletal Reorganization by Mycophenolic Acid Alters Mesangial Cell Migration and Contractility , 2003, Hypertension.

[3]  Y. Quiroz,et al.  Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. , 2003, Kidney international.

[4]  J. Bonnet,et al.  Mycophenolic acid antagonizes the activation of cultured human mesangial cells. , 2002, Kidney international.

[5]  Chul-woo Yang,et al.  Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity. , 2002, Kidney international.

[6]  J. Fink,et al.  Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. , 2001, Kidney international.

[7]  G. Owens,et al.  Smooth Muscle Differentiation Marker Gene Expression Is Regulated by RhoA-mediated Actin Polymerization* , 2001, The Journal of Biological Chemistry.

[8]  L. Renders,et al.  Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  D. Serón,et al.  Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. , 1998, Transplantation.

[10]  A. Wolf,et al.  Cyclosporine A-induced contraction of isolated rat aortic smooth muscle cells. , 1997, Life sciences.

[11]  C. Combe,et al.  Cyclosporin-A- and angiotensin-II-induced vasoreactivity in isolated glomeruli and cultured mesangial cells, 4 and 24 h after renal mass reduction: role of vasodilatory prostaglandins. , 1997, Nephron.

[12]  M. Myllärniemi,et al.  Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. , 1995, Transplant immunology.

[13]  G. Owens,et al.  The Smooth Muscle α-Actin Gene Promoter Is Differentially Regulated in Smooth Muscle versus Non-smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[14]  J. Conger,et al.  Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. , 1993, The Journal of clinical investigation.

[15]  J. Bonnet,et al.  Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  M. Carrier,et al.  Dose-dependent effect of cyclosporin on renal arterial resistance in dogs. , 1991, The American journal of physiology.

[17]  P. Klotman,et al.  Cellular and molecular mechanisms of cyclosporin nephrotoxicity. , 1990, Journal of the American Society of Nephrology : JASN.

[18]  A. Olivera,et al.  Actions of cyclosporin A on cultured rat mesangial cells. , 1989, Kidney international.